Related Experiment Video
Updated: Jun 13, 2026
03:22
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Primary pulmonary coccidioidomycosis in China
Fen Lan1, Yao-Zhi Tong, Hong Huang
1Department of Respiratory Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Respirology (Carlton, Vic.)
|April 23, 2010
Summary
A rare fungal infection, coccidioidomycosis, was diagnosed in a teen in China, a non-endemic area. Prompt treatment with antifungals led to a full recovery, highlighting the importance of considering endemic diseases in non-endemic regions.
Area of Science:
- Mycology
- Infectious Diseases
- Pulmonology
Background:
- Coccidioidomycosis is a fungal infection endemic to specific regions of the Americas.
- Cases outside endemic areas are rare, posing diagnostic challenges.
- Primary pulmonary coccidioidomycosis typically presents with non-specific respiratory symptoms.
Purpose of the Study:
- To report a case of primary pulmonary coccidioidomycosis in a non-endemic country.
- To describe the clinical presentation, diagnosis, and treatment of this rare infection.
- To emphasize the importance of considering endemic fungal infections in differential diagnoses.
Main Methods:
- A case study of a 14-year-old boy presenting with symptoms of pulmonary infection.
- Histological examination of a transbronchial biopsy showing Coccidioides immitis.
- Treatment with amphotericin B and fluconazole.
Main Results:
- Diagnosis of primary pulmonary coccidioidomycosis confirmed by histology.
- Successful treatment with a combination of amphotericin B and fluconazole.
- Complete recovery observed at 6-month follow-up.
Conclusions:
- Coccidioidomycosis can occur in non-endemic regions, necessitating awareness among clinicians.
- Early diagnosis and appropriate antifungal therapy are crucial for favorable outcomes.
- This case highlights the potential for geographic spread of endemic fungal infections.
Related Concept Videos
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...